EA
REPL icon

Emerald Advisers’s Replimune Group REPL Stock Holding History

Emerald Advisers’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-492,219
Closed -$4.02M – 268
2024
Q1 		$4.02M Sell
492,219
-46,622
-9% -$382K 0.16% 116
2023
Q4 		$4.54M Sell
538,841
-513,683
-49% -$5.96M 0.19% 114
2023
Q3 		$18M Sell
1,052,524
-33,763
-3% -$663K 0.87% 45
2023
Q2 		$25.2M Buy
1,086,287
+123,246
+13% +$2.41M 1.1% 30
2023
Q1 		$17M Sell
963,041
-223,000
-19% -$5.3M 0.82% 51
2022
Q4 		$32.3M Buy
1,186,041
+49,455
+4% +$1.03M 1.56% 10
2022
Q3 		$19.6M Buy
1,136,586
+43,263
+4% +$825K 1.01% 34
2022
Q2 		$19.1M Sell
1,093,323
-40,689
-4% -$668K 0.98% 36
2022
Q1 		$19.3M Buy
1,134,012
+144,054
+15% +$2.72M 0.73% 57
2021
Q4 		$26.8M Buy
989,958
+68,183
+7% +$2.04M 0.99% 37
2021
Q3 		$27.3M Buy
921,775
+189,533
+26% +$6.16M 0.99% 37
2021
Q2 		$28.1M Sell
732,242
-205,759
-22% -$7.04M 1.03% 33
2021
Q1 		$28.6M Buy
938,001
+55,537
+6% +$2.08M 1.03% 26
2020
Q4 		$33.7M Sell
882,464
-9,297
-1% -$387K 1.12% 21
2020
Q3 		$20.5M Buy
891,761
+39,258
+5% +$895K 0.84% 45
2020
Q2 		$21.2M Buy
852,503
+56,903
+7% +$1.01M 0.92% 44
2020
Q1 		$7.93M Buy
795,600
+2,006
+0.3% +$29.9K 0.46% 81
2019
Q4 		$11.4M Buy
793,594
+64,704
+9% +$932K 0.48% 88
2019
Q3 		$10.1M Buy
728,890
+35,712
+5% +$438K 0.47% 84
2019
Q2 		$10.2M Sell
693,178
-4,720
-0.7% -$68.3K 0.41% 91
2019
Q1 		$10.6M Buy
697,898
+46,428
+7% +$579K 0.43% 89
2018
Q4 		$6.51M Buy
651,470
+33,390
+5% +$451K 0.32% 100
2018
Q3 		$9.95M Buy
+618,080
New +$10.8M 0.37% 106

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Emerald Advisers's REPL Position: Q2 2024 in Review

Emerald Advisers sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 492,219 shares — an estimated $4.02M sold.

Emerald Advisers first reported a position in REPL in Q3 2018 and held it in 23 quarters. The position peaked at $33.7M in Q4 2020. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Emerald Advisers reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Emerald Advisers sold 492,219 Replimune Group shares in Q2 2024, an estimated $4.02M.
  • Emerald Advisers first reported a position in Replimune Group in Q3 2018 and held it in 23 quarters.
  • Emerald Advisers's Replimune Group position peaked at $33.7M in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Emerald Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.